Vaxxinity Inc - Ordinary Shares - Class A

NASDAQ:VAXX   9:30:00 AM EDT
7.74
-0.20 (-2.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Vaxxinity Inc - Ordinary Shares - Class A Stock, NASDAQ:VAXX

1717 Main Street, Suite 3388, Dallas, Texas 75201
United States of America
Phone: +1.245.244.5739
Number of Employees:

Description

Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimerâ??s, Parkinsonâ??s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Dallas, TX.